42 results on '"Oniscu, Gabriel C"'
Search Results
2. Normothermic machine perfusion versus static cold storage in donation after circulatory death kidney transplantation: a randomized controlled trial
- Author
-
Hosgood, Sarah A., Callaghan, Christopher J., Wilson, Colin H., Smith, Laura, Mullings, Joanne, Mehew, Jennifer, Oniscu, Gabriel C., Phillips, Benedict L., Bates, Lucy, and Nicholson, Michael L.
- Published
- 2023
- Full Text
- View/download PDF
3. Contemporary Management of Median Arcuate Ligament in Liver Transplantation
- Author
-
Babu, Benoy I. and Oniscu, Gabriel C.
- Published
- 2022
- Full Text
- View/download PDF
4. A propensity score–matched analysis indicates screening for asymptomatic coronary artery disease does not predict cardiac events in kidney transplant recipients
- Author
-
Nimmo, Ailish, Forsyth, John L., Oniscu, Gabriel C., Robb, Matthew, Watson, Christopher, Fotheringham, James, Roderick, Paul J., Ravanan, Rommel, and Taylor, Dominic M.
- Published
- 2021
- Full Text
- View/download PDF
5. SARS-CoV-2 infection and early mortality of waitlisted and solid organ transplant recipients in England: A national cohort study
- Author
-
Ravanan, Rommel, Callaghan, Chris J., Mumford, Lisa, Ushiro-Lumb, Ines, Thorburn, Douglas, Casey, John, Friend, Peter, Parameshwar, Jayan, Currie, Ian, Burnapp, Lisa, Baker, Richard, Dudley, Jan, Oniscu, Gabriel C., Berman, Marius, Asher, John, Harvey, Dan, Manara, Alex, Manas, Derek, Gardiner, Dale, and Forsythe, John L.R.
- Published
- 2020
- Full Text
- View/download PDF
6. Maintaining the permanence principle for death during in situ normothermic regional perfusion for donation after circulatory death organ recovery: A United Kingdom and Canadian proposal
- Author
-
Manara, Alex, Shemie, Sam D., Large, Stephen, Healey, Andrew, Baker, Andrew, Badiwala, Mitesh, Berman, Marius, Butler, Andrew J., Chaudhury, Prosanto, Dark, John, Forsythe, John, Freed, Darren H., Gardiner, Dale, Harvey, Dan, Hornby, Laura, MacLean, Janet, Messer, Simon, Oniscu, Gabriel C., Simpson, Christy, Teitelbaum, Jeanne, Torrance, Sylvia, Wilson, Lindsay C., and Watson, Christopher J.E.
- Published
- 2020
- Full Text
- View/download PDF
7. European Society for Organ Transplantation (ESOT) Consensus Statement on Outcome Measures in Liver Transplantation According to Value-Based Health Care.
- Author
-
Carbone, Marco, Neuberger, James, Rowe, Ian, Polak, Wojciech G., Forsberg, Anna, Fondevila, Constantino, Mantovani, Lorenzo, Nardi, Alessandra, Colli, Agostino, Rockell, Karen, Schick, Liz, Cristoferi, Laura, Oniscu, Gabriel C., Strazzabosco, Mario, and Cillo, Umberto
- Subjects
LIVER transplantation ,TRANSPLANTATION of organs, tissues, etc. ,VALUE-based healthcare ,MEDICAL care ,LIVER diseases - Abstract
Liver transplantation is a highly complex, life-saving, treatment for many patients with advanced liver disease. Liver transplantation requires multidisciplinary teams, system-wide adaptations and significant investment, as well as being an expensive treatment. Several metrics have been proposed to monitor processes and outcomes, however these lack patient focus and do not capture all aspects of the process. Most of the reported outcomes do not capture those outcomes that matter to the patients. Adopting the principles of Value-Based Health Care (VBHC), may provide an opportunity to develop those metrics that matter to patients. In this article, we present a Consensus Statement on Outcome Measures in Liver Transplantation following the principles of VBHC, developed by a dedicated panel of experts under the auspices of the European Society of Organ Transplantation (ESOT) Guidelines’ Taskforce. The overarching goal is to provide a framework to facilitate the development of outcome measures as an initial step to apply the VMC paradigm to liver transplantation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. In situ normothermic perfusion of livers in controlled circulatory death donation may prevent ischemic cholangiopathy and improve graft survival
- Author
-
Watson, Christopher J.E., Hunt, Fiona, Messer, Simon, Currie, Ian, Large, Stephen, Sutherland, Andrew, Crick, Keziah, Wigmore, Stephen J., Fear, Corrina, Cornateanu, Sorina, Randle, Lucy V., Terrace, John D., Upponi, Sara, Taylor, Rhiannon, Allen, Elisa, Butler, Andrew J., and Oniscu, Gabriel C.
- Published
- 2019
- Full Text
- View/download PDF
9. Impact of body mass index in liver transplantation for nonalcoholic fatty liver disease and alcoholic liver disease
- Author
-
O'Neill, Stephen, Napetti, Sara, Cornateanu, Sorina, Sutherland, Andrew I., Wigmore, Stephen, Oniscu, Gabriel C., and Adair, Anya
- Published
- 2017
- Full Text
- View/download PDF
10. Estimating Health-State Utility Values in Kidney Transplant Recipients and Waiting-List Patients Using the EQ-5D-5L
- Author
-
Li, Bernadette, Cairns, John A., Draper, Heather, Dudley, Christopher, Forsythe, John L., Johnson, Rachel J., Metcalfe, Wendy, Oniscu, Gabriel C., Ravanan, Rommel, Robb, Matthew L., Roderick, Paul, Tomson, Charles R., Watson, Christopher J.E., and Bradley, J. Andrew
- Published
- 2017
- Full Text
- View/download PDF
11. European Society for Organ Transplantation (ESOT) Consensus Statement on the Role of Pancreas Machine Perfusion to Increase the Donor Pool for Beta Cell Replacement Therapy.
- Author
-
Ferrer-Fàbrega, Joana, Mesnard, Benoît, Messner, Franka, Doppenberg, Jason B., Drachenberg, Cinthia, Engelse, Marten A., Johnson, Paul R. V., Leuvenink, Henri G. D., Oniscu, Gabriel C., Papalois, Vassilios, Ploeg, Rutger J., Reichman, Trevor W., Scott III, William E., Vistoli, Fabio, Berney, Thierry, Jacobs-Tulleneers-Thevissen, Daniel, Kessaris, Nicos, Weissenbacher, Annemarie, Ogbemudia, Ann Etohan, and White, Steve
- Subjects
PANCREATIC beta cells ,TRANSPLANTATION of organs, tissues, etc. ,PANCREAS ,CELLULAR therapy ,PERFUSION - Abstract
The advent of Machine Perfusion (MP) as a superior form of preservation and assessment for cold storage of both high-risk kidney's and the liver presents opportunities in the field of beta-cell replacement. It is yet unknown whether such techniques, when applied to the pancreas, can increase the pool of suitable donor organs as well as ameliorating the effects of ischemia incurred during the retrieval process. Recent experimental models of pancreatic MP appear promising. Applications of MP to the pancreas, needs refinement regarding perfusion protocols and organ viability assessment criteria. To address the "Role of pancreas machine perfusion to increase the donor pool for beta cell replacement," the European Society for Organ Transplantation (ESOT) assembled a dedicated working group comprising of experts to review literature pertaining to the role of MP as a method of improving donor pancreas quality as well as quantity available for transplant, and to develop guidelines founded on evidence-based reviews in experimental and clinical settings. These were subsequently refined during the Consensus Conference when this took place in Prague. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
12. The 3-Step Model of informed consent for living kidney donation: a proposal on behalf of the DESCaRTES Working Group of the European Renal Association.
- Author
-
Grossi, Alessandra Agnese, Sever, Mehmet Sukru, Hellemans, Rachel, Mariat, Christophe, Crespo, Marta, Watschinger, Bruno, Peruzzi, Licia, Demir, Erol, Velioglu, Arzu, Gandolfini, Ilaria, Oniscu, Gabriel C, Hilbrands, Luuk, and Mjoen, Geir
- Subjects
RENAL replacement therapy ,KIDNEYS ,KIDNEY transplantation ,NEPHROLOGISTS - Abstract
Living donation challenges the ethical principle of non-maleficence in that it exposes healthy persons to risks for the benefit of someone else. This makes safety, informed consent (IC) and education a priority. Living kidney donation has multiple benefits for the potential donor, but there are also several known short- and long-term risks. Although complete standardization of IC is likely to be unattainable, studies have emphasized the need for a standardized IC process to enable equitable educational and decision-making prospects for the prevention of inequities across transplant centers. Based on the Three-Talk Model of shared decision-making by Elwyn et al. we propose a model, named 3-Step (S) Model, where each step coincides with the three ideal timings of the process leading the living donor to the decision to pursue living donation: prior to the need for kidney replacement therapy (team talk); at the local nephrology unit or transplant center, with transplant clinicians and surgeons prior to evaluations start (option talk); and throughout evaluation, after having learned about the different aspects of donation, especially if there are second thoughts or doubts (decision talk). Based on the 3-S Model, to deliver conceptual and practical guidance to nephrologists and transplant clinicians, we provide recommendations for standardization of the timing, content, modalities for communicating risks and assessment of understanding prior to donation. The 3-S Model successfully allows an integration between standardization and individualization of IC, enabling a person-centered approach to potential donors. Studies will assess the effectiveness of the 3-S Model in kidney transplant clinical practice. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
13. Long-term risks of kidney living donation: review and position paper by the ERA-EDTA DESCARTES working group
- Author
-
Maggiore, Umberto, Budde, Klemens, Heemann, Uwe, Hilbrands, Luuk, Oberbauer, Rainer, Oniscu, Gabriel C., Pascual, Julio, Sorensen, Soren Schwartz, Viklicky, Ondrej, and Abramowicz, Daniel
- Published
- 2017
- Full Text
- View/download PDF
14. Sir Roy Calne, the Founding President of ESOT.
- Author
-
Oniscu, Gabriel C.
- Subjects
- *
TRANSPLANTATION of organs, tissues, etc. , *LIVER transplantation - Abstract
Sir Roy Calne, a pioneer in the field of transplantation, passed away on January 6th, leaving behind a significant legacy. Throughout his career, Calne focused on innovation and improving the outcomes of transplantation through surgical techniques and immunosuppressive therapies. He recognized the importance of collaboration and education in the field and played a key role in the formation of the European Society for Organ Transplantation (ESOT) in 1982. Calne's philosophy of multidisciplinarity continues to shape ESOT today. His passing marks the end of an era, but his influence lives on through the generations he inspired and the visionary society he helped nurture. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
15. Issues regarding COVID-19 in kidney transplantation in the ERA of the Omicron variant: a commentary by the ERA Descartes Working Group.
- Author
-
Gandolfini, Ilaria, Crespo, Marta, Hellemans, Rachel, Maggiore, Umberto, Mariat, Christophe, Mjoen, Geir, Oniscu, Gabriel C, Peruzzi, Licia, Sever, Mehmet Sükrü, Watschinger, Bruno, and Hilbrands, Luuk
- Subjects
SARS-CoV-2 ,SARS-CoV-2 Omicron variant ,KIDNEY transplantation ,COVID-19 ,CORONAVIRUS disease treatment ,CORONAVIRUS diseases - Abstract
The Omicron variant, which has become the dominant strain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) worldwide, brings new challenges to preventing and controlling the infection. Moreover, the widespread implementation of vaccination policies before and after transplantation, and the development of new prophylactic and treatment strategies for coronavirus disease 2019 (COVID-19) over the past 12–18 months, has raised several new issues concerning kidney transplant recipients. In this special report, the ERA DESCARTES (Developing Education Science and Care for Renal Transplantation in European States) Working Group addresses several questions related to everyday clinical practice concerning kidney transplant recipients and to the assessment of deceased and live kidney donors: what is the current risk of severe disease and of breakthrough infection, the optimal management of immunosuppression in kidney transplant recipients with COVID-19, the role of passive immunization and the efficacy of antiviral drugs in ambulatory patients, the management of drug-to-drug interactions, safety criteria for the use of SARS-CoV-2-positive donors, issues related to the use of T cell depleting agents as induction treatment, and current recommendations for shielding practices. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
16. Patient attitudes towards kidney transplant listing: qualitative findings from the ATTOM study
- Author
-
Calestani, Melania, Tonkin-Crine, Sarah, Pruthi, Rishi, Leydon, Geraldine, Ravanan, Rommel, Bradley, J. Andrew, Tomson, Charles R., Forsythe, John L., Oniscu, Gabriel C., Bradley, Clare, Cairns, John, Dudley, Christopher, Watson, Christopher, Draper, Heather, Johnson, Rachel J., Metcalfe, Wendy, Fogarty, Damian G., and Roderick, Paul
- Published
- 2014
- Full Text
- View/download PDF
17. Assessment of pre-donation glomerular filtration rate: going back to basics.
- Author
-
Mariat, Christophe, Mjøen, Geir, Watschinger, Bruno, Sever, Mehmet Sukru, Crespo, Marta, Peruzzi, Licia, Oniscu, Gabriel C, Abramowicz, Daniel, Hilbrands, Luuk, and Maggiore, Umberto
- Subjects
GLOMERULAR filtration rate ,CHRONIC kidney failure ,DISEASE risk factors ,KIDNEY diseases - Abstract
The 2017 version of the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines is the most recent international framework for the evaluation and care of living kidneys donors. Along with the call for an integrative approach evaluating the long-term end-stage kidney disease risk for the future potential donor, several recommendations are formulated regarding the pre-donation glomerular filtration rate (GFR) adequacy with no or little consideration for the donor candidate's age or for the importance of using reference methods of GFR measurements. Herein, we question the position of the KDIGO guidelines and discuss the rationale and modalities for a more basic, but no less demanding GFR evaluation enabling a more efficient selection of potential kidney donors. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
18. Tissue Proteomic Analysis Identifies Mechanisms and Stages of Immunopathology in Fatal COVID-19.
- Author
-
Russell, Clark D., Valanciute, Asta, Gachanja, Naomi N., Stephen, Jillian, Penrice-Randal, Rebekah, Armstrong, Stuart D., Clohisey, Sara, Bo Wang, Al Qsous, Wael, Wallace, William A., Oniscu, Gabriel C., Stevens, Jo, Harrison, David J., Dhaliwal, Kevin, Hiscox, Julian A., Baillie, J. Kenneth, Akram, Ahsan R., Dorward, David A., and Lucas, Christopher D.
- Subjects
IMMUNOPATHOLOGY ,CORONAVIRUS diseases ,PROTEOMICS ,TISSUE analysis ,MACROPHAGE colony-stimulating factor - Abstract
Immunopathology occurs in the lung and spleen in fatal coronavirus disease (COVID-19), involving monocytes/macrophages and plasma cells. Antiinflammatory therapy reduces mortality, but additional therapeutic targets are required. We aimed to gain mechanistic insight into COVID-19 immunopathology by targeted proteomic analysis of pulmonary and splenic tissues. Lung parenchymal and splenic tissue was obtained from 13 postmortem examinations of patients with fatal COVID-19. Control tissue was obtained from cancer resection samples (lung) and deceased organ donors (spleen). Protein was extracted from tissue by phenol extraction. Olink multiplex immunoassay panels were used for protein detection and quantification. Proteins with increased abundance in the lung included MCP-3, antiviral TRIM21, and prothrombotic TYMP. OSM and EN-RAGE/S100A12 abundance was correlated and associated with inflammation severity. Unsupervised clustering identified "early viral" and "late inflammatory" clusters with distinct protein abundance profiles, and differences in illness duration before death and presence of viral RNA. In the spleen, lymphocyte chemotactic factors and CD8A were decreased in abundance, and proapoptotic factors were increased. B-cell receptor signaling pathway components and macrophage colony stimulating factor (CSF-1) were also increased. Additional evidence for a subset of host factors (including DDX58, OSM, TYMP, IL-18, MCP-3, and CSF-1) was provided by overlap between 1) differential abundance in spleen and lung tissue; 2) meta-analysis of existing datasets; and 3) plasma proteomic data. This proteomic analysis of lung parenchymal and splenic tissue from fatal COVID-19 provides mechanistic insight into tissue antiviral responses, inflammation and disease stages, macrophage involvement, pulmonary thrombosis, splenic B-cell activation, and lymphocyte depletion. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
19. Management of obesity in kidney transplant candidates and recipients: A clinical practice guideline by the DESCARTES Working Group of ERA.
- Author
-
Oniscu, Gabriel C, Abramowicz, Daniel, Bolignano, Davide, Gandolfini, Ilaria, Hellemans, Rachel, Maggiore, Umberto, Nistor, Ionut, O'Neill, Stephen, Sever, Mehmet Sukru, Koobasi, Muguet, and Nagler, Evi V
- Subjects
- *
KIDNEY transplantation , *ORGAN transplant waiting lists , *MEDICAL personnel , *NEPHROLOGISTS , *CHRONIC kidney failure , *GENERAL practitioners , *OBESITY - Abstract
The clinical practice guideline Management of Obesity in Kidney Transplant Candidates and Recipients was developed to guide decision-making in caring for people with end-stage kidney disease (ESKD) living with obesity. The document considers the challenges in defining obesity, weighs interventions for treating obesity in kidney transplant candidates as well as recipients and reflects on the impact of obesity on the likelihood of wait-listing as well as its effect on transplant outcomes. It was designed to inform management decisions related to this topic and provide the backdrop for shared decision-making. This guideline was developed by the European Renal Association's Developing Education Science and Care for Renal Transplantation in European States working group. The group was supplemented with selected methodologists to supervise the project and provide methodological expertise in guideline development throughout the process. The guideline targets any healthcare professional treating or caring for people with ESKD being considered for kidney transplantation or having received a donor kidney. This includes nephrologists, transplant physicians, transplant surgeons, general practitioners, dialysis and transplant nurses. Development of this guideline followed an explicit process of evidence review. Treatment approaches and guideline recommendations are based on systematic reviews of relevant studies and appraisal of the quality of the evidence and the strength of recommendations followed the Grading of Recommendations Assessment, Development and Evaluation approach. Limitations of the evidence are discussed and areas of future research are presented. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
20. Addressing ethical confusion in deceased donation and transplantation research: the need for dedicated guidance.
- Author
-
Martin, Dominique E., Cronin, Antonia J., Dalle Ave, Anne, van Haren, Frank M. P., Locke, Jayme E., Miñambres, Eduardo, Oniscu, Gabriel C., and Parent, Brendan
- Subjects
DEAD ,TRANSPLANTATION of organs, tissues, etc. ,TREATMENT effectiveness ,CRITICALLY ill ,MEDICAL research - Abstract
Summary: Innovative research in deceased donation and transplantation often presents ethical challenges for researchers and those responsible for ethical governance of research. These challenges have been recognized as potential barriers to the conduct of research. We review the literature to identify and describe ethical considerations that may cause confusion or uncertainty in the context of research involving potential deceased donors or deceased donor transplantation. We normatively examine these considerations and discuss their implications for the ethical conduct of research. In addition to the complexities of research involving critically ill, dying or recently deceased individuals, uncertainty may arise regarding the ethical status of various individuals who may be involved in research aimed at improving availability and outcomes of organ transplantation. Consequently, routine ethical guidelines for clinical research may fail to provide clear guidance with regards to the design, conduct and governance of some deceased donation or transplantation studies. Ethical uncertainty may result in delays or barriers to research, or neglect of important ethical considerations. Specific ethical guidance is needed to support research in deceased donation and transplantation as the ethical considerations that arise in the design and conduct of such research may not be addressed in the existing guidelines for human research. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
21. Disruptive Innovation, Trusted Care.
- Author
-
Oniscu, Gabriel C.
- Subjects
- *
DISRUPTIVE innovations , *TRUST - Published
- 2023
- Full Text
- View/download PDF
22. Have we reached the limits in altruistic kidney donation?
- Author
-
Thomas, Rachel, Consolo, Henrietta, and Oniscu, Gabriel C.
- Subjects
KIDNEYS ,KIDNEY transplantation ,RISK assessment ,SOCIAL media ,PROCESS optimization - Abstract
Summary: Altruistic donation (unspecified donation) is an important aspect of living donor kidney transplantation. Although donation to a stranger is lawful and supported in many countries, it remains uncommon and not actively promoted. Herein, we ask the question if we have reached the limit in altruistic donation. In doing so, we examine important ethical questions that define the limits of unspecified donation, such as the appropriate balance between autonomous decision‐making and paternalistic protection of the donor, the extent of outcome uncertainty and risk‐benefit analyses that donors should be allowed to accept. We also consider the scrutiny and acceptance of donor motives, the potential for commercialization, donation to particular categories of recipients (including those encountered through social media) and the ethical boundaries of active promotion of unspecified kidney donation. We conclude that there is scope to increase the number of living donation kidney transplants further by optimizing existing practices to support and promote unspecified donation. A number of strategies including optimization of the assessment process, innovative approaches to reach potential donors together with reimbursement of expenses and a more specific recognition of unspecified donation are likely to lead to a meaningful increase in this type of donation. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
23. Pancreas utilization rates in the UK – an 11‐year analysis.
- Author
-
Cornateanu, Sorina M., O'Neill, Stephen, Dholakia, Sham, Counter, Claire J., Sherif, Ahmed E., Casey, John J., Friend, Peter, and Oniscu, Gabriel C.
- Subjects
PANCREAS ,TRANSPLANTATION of organs, tissues, etc. - Abstract
Summary: Utilization of pancreases for transplantation remains inferior to that of other organs. Herein, we analysed UK pancreas discards to identify the reasons for the low utilization rates. Data on all pancreases offered first for solid organ transplantation between 1st January 2005 and 31st December 2015 were extracted from the UK Transplant Registry. The number of organs discarded, reasons and the time point of discard were analysed. A centre specific comparison was also undertaken. 7367 pancreases were offered first for solid organ transplantation. 35% were donors after circulatory death (DCD). 3668 (49.7%) organs were not retrieved. Of the 3699 pancreases retrieved, 38% were initially accepted but subsequently discarded. 2145 (29%) grafts offered were transplanted as simultaneous pancreas‐kidney or solitary pancreas. 1177 (55%) were transplanted on the first offer whilst the remaining 968 were transplanted after a median of three offers. 52% DBD pancreases were accepted and transplanted on the first offer compared with 68% DCD grafts. There were significant differences in discard rates between centres (30–80% for DBD and 3–78% for DCD, P < 0.001). A significant number of solid pancreases are discarded. Better graft assessment at retrieval could minimize unnecessary organ travel and discards. Closer links with islet programmes may allow for better utilization of discarded grafts. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
24. The trials and tribulations of liver allocation.
- Author
-
Lee, Eunice, Johnston, Chris J. C., and Oniscu, Gabriel C.
- Subjects
LIVER transplantation ,LIVER ,LANDSCAPE changes ,LOCAL government ,ALGORITHMS - Abstract
Summary: Allocation policies are necessary to ensure a fair distribution of a scarce resource. The goal of any liver transplant allocation policy is to achieve the best possible outcomes for the waiting list population, irrespective of the indication for transplant, whilst maximizing organ utilization. Organ allocation for liver transplantation has evolved from simple centre‐based approaches driven by local issues, to complex, evidence‐based algorithm prioritizing according to need. Despite the rapid evolution of allocation policies, there remain a number of challenges and new approaches are required to ensure transparency and equity on the decision‐making process and the best possible outcomes for patients on the waiting list. New ways of modelling, together with novel outcome criteria, will be required to enable a dynamic adaptability of the allocation policies to the ever changing demographics of the donor population and the changing landscape of indications for transplantation. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
25. Changes in quality of life, health status and other patient‐reported outcomes following simultaneous pancreas and kidney transplantation (SPKT): a quantitative and qualitative analysis within a UK‐wide programme.
- Author
-
Gibbons, Andrea, Cinnirella, Marco, Bayfield, Janet, Watson, Christopher J. E., Oniscu, Gabriel C., Draper, Heather, Tomson, Charles R. V., Ravanan, Rommel, Johnson, Rachel J., Forsythe, John, Dudley, Chris, Metcalfe, Wendy, Bradley, J. Andrew, and Bradley, Clare
- Subjects
KIDNEY transplantation ,BLOOD sugar monitoring ,PANCREAS ,QUALITY of life ,DIABETES complications - Abstract
We examined quality of life (QoL) and other patient‐reported outcome measures (PROMs) in 95 simultaneous pancreas and kidney transplant (SPKT) recipients and 41 patients wait‐listed for SPKT recruited to the UK Access to Transplantation and Transplant Outcome Measures (ATTOM) programme. Wait‐listed patients transplanted within 12 months of recruitment (n = 22) were followed 12 months post‐transplant and compared with those still wait‐listed (n = 19) to examine pre‐ to post‐transplant changes. Qualitative interviews with ten SPKT recipients 12 months post‐transplant were analysed thematically. Cross‐sectional analyses showed several better 12‐month outcomes for SPKT recipients compared with those still wait‐listed, a trend to better health utilities but no difference in diabetes‐specific QoL or diabetes treatment satisfaction. Pre‐ to post‐transplant, SPKT recipients showed improved treatment satisfaction, well‐being, self‐reported health, generic QoL and less negative impact on renal‐specific QoL (ps < 0.05). Health utility values were better overall in transplant recipients and neither these nor diabetes‐specific QoL changed significantly in either group. Pre‐emptive transplant advantages seen in 12‐month cross‐sectional analyses disappeared when controlling for baseline values. Qualitative findings indicated diabetes complications, self‐imposed blood glucose monitoring and dietary restrictions continued to impact QoL negatively post‐transplant. Unrealistic expectations of SPKT caused some disappointment. Measuring condition‐specific PROMs over time will help in demonstrating the benefits and limitations of SPKT. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
26. How should I manage immunosuppression in a kidney transplant patient with COVID-19? An ERA-EDTA DESCARTES expert opinion.
- Author
-
Maggiore, Umberto, Abramowicz, Daniel, Crespo, Marta, Mariat, Christophe, Mjoen, Geir, Peruzzi, Licia, Sever, Mehmet Sükrü, Oniscu, Gabriel C, Hilbrands, Luuk, and Watschinger, Bruno
- Subjects
COVID-19 ,KIDNEY transplantation ,SARS-CoV-2 ,THERAPEUTICS ,MEDICAL practice - Published
- 2020
- Full Text
- View/download PDF
27. Equity–Efficiency Trade-offs Associated With Alternative Approaches to Deceased Donor Kidney Allocation: A Patient-level Simulation.
- Author
-
Li, Bernadette, Cairns, John A., Johnson, Rachel J., Watson, Christopher J.E., Roderick, Paul, Oniscu, Gabriel C., Metcalfe, Wendy, Bradley, J. Andrew, Tomson, Charles R., Draper, Heather, Forsythe, John L., Dudley, Christopher, and Ravanan, Rommel
- Published
- 2020
- Full Text
- View/download PDF
28. Standard work-up of the low-risk kidney transplant candidate: a European expert survey of the ERA-EDTA Developing Education Science and Care for Renal Transplantation in European States Working Group.
- Author
-
Maggiore, Umberto, Abramowicz, Daniel, Budde, Klemens, Crespo, Marta, Mariat, Christophe, Oberbauer, Rainer, Pascual, Julio, Peruzzi, Licia, Sorensen, Soren Schwartz, Viklicky, Ondrej, Watschinger, Bruno, Oniscu, Gabriel C, Heemann, Uwe, Hilbrands, Luuk B, and Group, ERA-EDTA DESCARTES Working
- Subjects
ORGAN transplant waiting lists ,KIDNEY transplantation ,SCIENCE education ,TEAMS in the workplace ,TRANSPLANTATION of organs, tissues, etc. ,CHRONIC kidney failure - Abstract
Background Existing guidelines on the evaluation and preparation of recipients for kidney transplantation target the entire spectrum of patients with end-stage renal disease. Within the ERA-EDTA Developing Education Science and Care for Renal Transplantation in European States (DESCARTES) Working Group, it was proposed that in a subset of relatively young patients (<40 years) without significant comorbidities (such as diabetes or cardiovascular disease), the work-up for transplantation could be restricted to a small set of tests. Methods Aiming for agreement between transplant centres across Europe, we surveyed the opinion of 80 transplant professionals from 11 European states on the composition of a minimal work-up. Results We show that there is a wide agreement among European experts that the work-up for kidney transplantation of the low-risk candidate, as opposed to the standard risk candidate, could include a limited number of investigations. However, there is some disagreement regarding the small number of diagnostic procedures, which is related to geographical location within Europe and the professional background of respondents. Conclusions Based on the results of the survey, published guidelines and expert meetings by the DESCARTES Working Group, we have formulated a proposal for the work-up of low-risk kidney transplant candidates. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
29. Pre-existing malignancies in renal transplant candidates—time to reconsider waiting times.
- Author
-
Watschinger, Bruno, Budde, Klemens, Crespo, Marta, Heemann, Uwe, Hilbrands, Luuk, Maggiore, Umberto, Mariat, Christophe, Oberbauer, Rainer, Oniscu, Gabriel C, Peruzzi, Licia, Sorensen, Søren S, Viklicky, Ondrej, Abramowicz, Daniel, and Group, ERA-EDTA DESCARTES Working
- Subjects
KIDNEY transplantation ,TIME - Abstract
Current proposals for waiting times for a renal transplant after malignant disease may not be appropriate. New data on malignancies in end-stage renal disease and recent diagnostic and therapeutic options should lead us to reconsider our current practice. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
30. Recent advances in kidney transplantation: a viewpoint from the Descartes advisory board.
- Author
-
Abramowicz, Daniel, Oberbauer, Rainer, Heemann, Uwe, Viklicky, Ondrej, Peruzzi, Licia, Mariat, Christophe, Crespo, Marta, Budde, Klemens, and Oniscu, Gabriel C
- Subjects
MEDICAL innovations ,KIDNEY transplantation ,HLA histocompatibility antigens ,IMMUNOSUPPRESSION ,FOCAL segmental glomerulosclerosis - Abstract
Transplantation medicine is a rapidly evolving field. Keeping afloat of the published literature to offer the best clinical care to our patients is a daunting task. As part of its educational mission, the Descartes advisory board identified seven topics in kidney transplantation where there has been substantial progresses over the last years: kidney allocation within Eurotransplant; kidney exchange strategies; kidney machine perfusion strategies; the changing landscape of anti-human leukocyte antigen (HLA) antibodies; the new immunosuppressive drugs in the pipeline; strategies for immunosuppression minimization; and the continuous enigma of focal segmental glomerular sclerosis recurrence after transplantation. Here, we have summarized the main knowledge and the main challenges of these seven topics with the aim to provide transplant professionals at large with key bullet points to successfully understand these new concepts. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
31. Health literacy and patient outcomes in chronic kidney disease: a systematic review.
- Author
-
Taylor, Dominic M, Fraser, Simon, Dudley, Chris, Oniscu, Gabriel C, Tomson, Charles, Ravanan, Rommel, Roderick, Paul, and investigators, the ATTOM
- Subjects
HEALTH literacy ,CHRONIC kidney failure ,TRANSPLANTATION of organs, tissues, etc. ,SOCIOECONOMICS ,CARDIOVASCULAR agents - Abstract
Background Limited health literacy affects 25% of people with chronic kidney disease (CKD), and may reduce self-management skills resulting in poorer clinical outcomes. By disproportionately affecting people with low socio-economic status and non-white ethnicity, limited health literacy may promote health inequity. Methods We performed a systematic review of quantitative studies of health literacy and clinical outcomes among adults with CKD. Results A total of 29 studies (13 articles; 16 conference abstracts) were included. One included non-USA patients. Of the 29 studies, 5 were cohort studies and 24 were cross-sectional. In all, 18 300 patients were studied: 4367 non-dialysis CKD; 13 202 dialysis; 390 transplant; 341 unspecified. Median study size was 127 [interquartile range (IQR) 92–238)], but 480 (IQR 260–2392) for cohort studies. Median proportion of non-white participants was 48% (IQR 17–70%). Six health literacy measures were used. Outcomes included patient attributes, care processes, clinical/laboratory parameters and ‘hard’ clinical outcomes. Limited health literacy was significantly, independently associated with hospitalizations, emergency department use, missed dialysis sessions, cardiovascular events and mortality (in cohort studies). Study quality was high (1 study), moderate (3 studies) and poor (25 studies), limited by sampling methods, variable adjustment for confounders and reduced methodological detail given in conference abstracts. Conclusions There is limited robust evidence of the causal effects of health literacy on patient outcomes in CKD. Available evidence suggests associations with adverse clinical events, increased healthcare use and mortality. Prospective studies are required to determine the causal effects of health literacy on outcomes in CKD patients, and examine the relationships between socio-economic status, comorbidity, health literacy and CKD outcomes. Intervention development and evaluation will determine whether health literacy is a modifiable determinant of poor outcomes in CKD. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
32. Barriers to living donor kidney transplantation in the United Kingdom: a national observational study.
- Author
-
Wu, Diana A., Robb, Matthew L., Watson, Christopher J. E., Forsythe, John L. R., Tomson, Charles R. V., Cairns, John, Roderick, Paul, Johnson, Rachel J., Ravanan, Rommel, Fogarty, Damian, Bradley, Clare, Gibbons, Andrea, Metcalfe, Wendy, Draper, Heather, Bradley, Andrew J., and Oniscu, Gabriel C.
- Subjects
KIDNEY diseases ,KIDNEY transplantation ,KIDNEY exchange ,SOCIODEMOGRAPHIC factors ,HEALTH equity - Abstract
Background. Living donor kidney transplantation (LDKT) provides more timely access to transplantation and better clinical outcomes than deceased donor kidney transplantation (DDKT). This study investigated disparities in the utilization of LDKT in the UK. Methods. A total of 2055 adults undergoing kidney transplantation between November 2011 and March 2013 were prospectively recruited from all 23 UK transplant centres as part of the Access to Transplantation and Transplant Outcome Measures (ATTOM) study. Recipient variables independently associated with receipt of LDKT versus DDKT were identified. Results. Of the 2055 patients, 807 (39.3%) received LDKT and 1248 (60.7%) received DDKT. Multivariable modelling demonstrated a significant reduction in the likelihood of LDKT for older age {odds ratio [OR] 0.11 [95% confidence interval (CI) 0.08-0.17], P<0.0001 for 65-75 years versus 18-34 years}; Asian ethnicity [OR 0.55 (95% CI 0.39-0.77), P=0.0006 versus White]; Black ethnicity [OR 0.64 (95% CI 0.42-0.99), P=0.047 versus White]; divorced, separated or widowed [OR 0.63 (95% CI 0.46-0.88), P=0.030 versus married]; no qualifications [OR 0.55 (95% CI 0.42-0.74), P<0.0001 versus higher education qualifications]; no car ownership [OR 0.51 (95% CI 0.37-0.72), P=0.0001] and no home ownership [OR 0.65 (95% CI 0.85-0.79), P=0.002]. The odds of LDKT varied significantly between countries in the UK. Conclusions. Among patients undergoing kidney transplantation in the UK, there are significant age, ethnic, socio-economic and geographic disparities in the utilization of LDKT. Further work is needed to explore the potential for targeted interventions to improve equity in living donor transplantation. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
33. Patient preferences, knowledge and beliefs about kidney allocation: qualitative findings from the UK-wide ATTOM programme.
- Author
-
Gibbons, Andrea, Cinnirella, Marco, Bayfield, Janet, Wu, Diana, Draper, Heather, Johnson, Rachel J., Tomson, Charles R. V., Forsythe, John L. R., Metcalfe, Wendy, Fogarty, Damian, Roderick, Paul, Ravanan, Rommel, Oniscu, Gabriel C., Watson, Christopher J. E., Bradley, J. Andrew, and Bradley, Clare
- Abstract
Objective: To explore how patients who are wait-listed for or who have received a kidney transplant understand the current UK kidney allocation system, and their views on ways to allocate kidneys in the future. Design: Qualitative study using semistructured interviews and thematic analysis based on a pragmatic approach. Participants: 10 deceased-donor kidney transplant recipients, 10 live-donor kidney transplant recipients, 12 participants currently wait-listed for a kidney transplant and 4 participants whose kidney transplant failed. Setting: Semistructured telephone interviews conducted with participants in their own homes across the UK. Results: Three main themes were identified: uncertainty of knowledge of the allocation scheme; evaluation of the system and participant suggestions for future allocation schemes. Most participants identified human leucocyte anitgen matching as a factor in determining kidney allocation, but were often uncertain of the accuracy of their knowledge. In the absence of information that would allow a full assessment, the majority of participants consider that the current system is effective. A minority of participants were concerned about the perceived lack of transparency of the general decision-making processes within the scheme. Most participants felt that people who are younger and those better matched to the donor kidney should be prioritised for kidney allocation, but in contrast to the current scheme, less priority was considered appropriate for longer waiting patients. Some non-medical themes were also discussed, such as whether parents of dependent children should be prioritised for allocation, and whether patients with substance abuse problems be deprioritised. Conclusions: Our participants held differing views about the most important factors for kidney allocation, some of which were in contrast to the current scheme. Patient participation in reviewing future allocation policies will provide insight as to what is considered acceptable to patients and inform healthcare staff of the kinds of information patients would find most useful. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
34. '5‐5‐500' – yet another extended criteria for HCC or a truly innovative development?
- Author
-
Oniscu, Gabriel C.
- Subjects
- *
TECHNICAL specifications , *LIVER transplantation , *CANCER relapse - Abstract
The article discusses about proposed liver transplantation criteria for hepatocellular carcinoma (HCC) patients to help them access transplantation. The criteria involved Japanese HCC patients undergoing living donor liver transplantation (LDLT). The criteria established thresholds for size of tumour, number of HCC nodules, and concentration of alpha-fetoprotein (AFP). The previously established Milan criteria is also noted.
- Published
- 2019
- Full Text
- View/download PDF
35. Predicting patient survival after deceased donor kidney transplantation using flexible parametric modelling.
- Author
-
Li, Bernadette, Cairns, John A., Robb, Matthew L., Johnson, Rachel J., Watson, Christopher J. E., Forsythe, John L., Oniscu, Gabriel C., Ravanan, Rommel, Dudley, Christopher, Roderick, Paul, Metcalfe, Wendy, Tomson, Charles R., and Bradley, J. Andrew
- Subjects
KIDNEY transplant patients ,PATIENTS ,COMPLICATIONS from organ transplantation ,SURVIVAL analysis (Biometry) ,EXTRAPOLATION ,ORGAN transplant waiting lists - Abstract
Background: The influence of donor and recipient factors on outcomes following kidney transplantation is commonly analysed using Cox regression models, but this approach is not useful for predicting long-term survival beyond observed data. We demonstrate the application of a flexible parametric approach to fit a model that can be extrapolated for the purpose of predicting mean patient survival. The primary motivation for this analysis is to develop a predictive model to estimate post-transplant survival based on individual patient characteristics to inform the design of alternative approaches to allocating deceased donor kidneys to those on the transplant waiting list in the United Kingdom.Methods: We analysed data from over 12,000 recipients of deceased donor kidney or combined kidney and pancreas transplants between 2003 and 2012. We fitted a flexible parametric model incorporating restricted cubic splines to characterise the baseline hazard function and explored a range of covariates including recipient, donor and transplant-related factors.Results: Multivariable analysis showed the risk of death increased with recipient and donor age, diabetic nephropathy as the recipient's primary renal diagnosis and donor hypertension. The risk of death was lower in female recipients, patients with polycystic kidney disease and recipients of pre-emptive transplants. The final model was used to extrapolate survival curves in order to calculate mean survival times for patients with specific characteristics.Conclusion: The use of flexible parametric modelling techniques allowed us to address some of the limitations of both the Cox regression approach and of standard parametric models when the goal is to predict long-term survival. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
36. Use of Renal Replacement Therapy May Influence Graft Outcomes following Liver Transplantation for Acute Liver Failure: A Propensity-Score Matched Population-Based Retrospective Cohort Study.
- Author
-
Knight, Stephen R., Oniscu, Gabriel C., Devey, Luke, Simpson, Kenneth J., Wigmore, Stephen J., and Harrison, Ewen M.
- Subjects
- *
LIVER transplantation , *LIVER failure , *COHORT analysis , *RETROSPECTIVE studies , *POPULATION-based case control , *HEALTH outcome assessment , *THERAPEUTICS - Abstract
Introduction: Acute kidney injury is associated with a poor prognosis in acute liver failure but little is known of outcomes in patients undergoing transplantation for acute liver failure who require renal replacement therapy. Methods: A retrospective analysis of the United Kingdom Transplant Registry was performed (1 January 2001–31 December 2011) with patient and graft survival determined using Kaplan-Meier methods. Cox proportional hazards models were used together with propensity-score based full matching on renal replacement therapy use. Results: Three-year patient and graft survival for patients receiving renal replacement therapy were 77.7% and 72.6% compared with 85.1% and 79.4% for those not requiring renal replacement therapy (P<0.001 and P = 0.009 respectively, n = 725). In a Cox proportional hazards model, renal replacement therapy was a predictor of both patient death (hazard ratio (HR) 1.59, 95% CI 1.01–2.50, P = 0.044) but not graft loss (HR 1.39, 95% CI 0.92–2.10, P = 0.114). In groups fully matched on baseline covariates, those not receiving renal replacement therapy with a serum creatinine greater than 175μmol/L had a significantly worse risk of graft failure than those receiving renal replacement therapy. Conclusion: In patients being transplanted for acute liver failure, use of renal replacement therapy is a strong predictor of patient death and graft loss. Those not receiving renal replacement therapy with an elevated serum creatinine may be at greater risk of early graft failure than those receiving renal replacement therapy. A low threshold for instituting renal replacement therapy may therefore be beneficial. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
37. Access to Transplantation and Transplant Outcome Measures (ATTOM): study protocol of a UK wide, in-depth, prospective cohort analysis.
- Author
-
Oniscu, Gabriel C., Ravanan, Rommel, Wu, Diana, Gibbons, Andrea, Li, Bernadette, Tomson, Charles, Forsythe, John L., Bradley, Clare, Cairns, John, Dudley, Christopher, Watson, Christopher J. E., Bolton, Eleanor M., Draper, Heather, Robb, Matthew, Bradbury, Lisa, Pruthi, Rishi, Metcalfe, Wendy, Fogarty, Damian, Roderick, Paul, and Bradley, J. Andrew
- Abstract
Introduction: There is significant intercentre variability in access to renal transplantation in the UK due to poorly understood factors. The overarching aims of this study are to improve equity of access to kidney and kidney-pancreas transplantation across the UK and to optimise organ allocation to maximise the benefit and cost-effectiveness of transplantation. Methods and analysis: 6844 patients aged 18-75 years starting dialysis and/or receiving a transplant together with matched patients active on the transplant list from all 72 UK renal units were recruited between November 2011 and March 2013 and will be followed for at least 3 years. The outcomes of interest include patient survival, access to the transplant list, receipt of a transplant, patient-reported outcome measures (PROMs) including quality of life, treatment satisfaction, well-being and health status on different forms of renal replacement therapy. Sociodemographic and clinical data were prospectively collected from case notes and from interviews with patients and local clinical teams. Qualitative process exploration with clinical staff will help identify unit-specific factors that influence access to renal transplantation. A health economic analysis will explore costs and outcomes associated with alternative approaches to organ allocation. The study will deliver: (1) an understanding of patient and unit-specific factors influencing access to renal transplantation in the UK, informing potential changes to practices and policies to optimise outcomes and reduce intercentre variability; (2) a patient-survival probability model to standardise access to the renal transplant list and (3) an understanding of PROMs and health economic impact of kidney and kidney-pancreas transplantation to inform the development of a more sophisticated and fairer organ allocation algorithm. Ethics and dissemination: The protocol has been independently peer reviewed by National Institute for Health Research (NIHR) and approved by the East of England Research Ethics Committee. The results will be published in peer-reviewed journals and presented at conferences. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
38. Challenges and advances in optimizing liver allografts from donation after circulatory death donors.
- Author
-
Sutherland, Andrew Ian and Oniscu, Gabriel C.
- Subjects
- *
LIVER transplantation , *TRANSPLANTATION of organs, tissues, etc. , *PRESERVATION of organs, tissues, etc. , *BRAIN stem , *ORGAN donors - Abstract
In recent years, there has been a shift in the donor demographics with an increase in donation after circulatory death (DCD). Livers obtained from DCD donors are known to have poorer outcomes when compared to donors after brainstem death and currently only a small proportion of DCD livers are used. This review outlines the recent technological developments in liver DCD donation, including clinical studies using normothermic regional perfusion and extracorporal machine perfusion of livers from DCD donors. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
39. Understanding cost of care for patients on renal replacement therapy: looking beyond fixed tariffs.
- Author
-
Li, Bernadette, Cairns, John A., Fotheringham, James, Tomson, Charles R., Forsythe, John L., Watson, Christopher, Metcalfe, Wendy, Fogarty, Damian G., Draper, Heather, Oniscu, Gabriel C., Dudley, Christopher, Johnson, Rachel J., Roderick, Paul, Leydon, Geraldine, Bradley, J. Andrew, and Ravanan, Rommel
- Subjects
KIDNEY transplantation ,HOSPITAL costs ,COMORBIDITY ,MEDICAL care costs ,HOSPITAL care - Abstract
Background. In a number of countries, reimbursement to hospitals providing renal dialysis services is set according to a fixed tariff. While the cost of maintenance dialysis and transplant surgery are amenable to a system of fixed tariffs, patients with established renal failure commonly present with comorbid conditions that can lead to variations in the need for hospitalization beyond the provision of renal replacement therapy. Methods. Patient-level cost data for incident renal replacement therapy patients in England were obtained as a result of linkage of the Hospital Episodes Statistics dataset to UK Renal Registry data. Regression models were developed to explore variations in hospital costs in relation to treatment modality, number of years on treatment and factors such as age and comorbidities. The final models were then used to predict annual costs for patients with different sets of characteristics. Results. Excluding the cost of renal replacement therapy itself, inpatient costs generally decreased with number of years on treatment for haemodialysis and transplant patients, whereas costs for patients receiving peritoneal dialysis remained constant. Diabetes was associated with higher mean annual costs for all patients irrespective of treatment modality and hospital setting. Age did not have a consistent effect on costs. Conclusions. Combining predicted hospital costs with the fixed costs of renal replacement therapy showed that the total cost differential for a patient continuing on dialysis rather than receiving a transplant is considerable following the first year of renal replacement therapy, thus reinforcing the longer- term economic advantage of transplantation over dialysis for the health service. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
40. Pushing the boundaries in liver graft utilisation in transplantation: Case report of a donor with previous bile duct injury repair.
- Author
-
Sultana, Asma, Powell, James J., and Oniscu, Gabriel C.
- Abstract
Introduction Liver transplantation is a recognised treatment for extensive bile duct injuries with secondary biliary cirrhosis or recurring sepsis. However, there have been no reports of successful liver transplantation from a donor who sustained a previous bile duct injury. Presentation of case Here we discuss the case of a liver transplant from a 51-year-old brain dead donor who had suffered a Strasberg E1 bile duct injury and had undergone a Roux-en-Y hepaticojejunostomy 24 years prior to donation. The liver was successfully recovered and transplanted into a 56-year-old male recipient with end stage liver disease consequent to alpha 1 antitrypsin deficiency. The graft continues to function well 36 months post-transplant, with normal liver function tests and imaging revealing a patent hepaticojejunostomy. Discussion The potential associated vascular injuries should be identified during bench preparation whilst the management of biliary reconstruction at the time of transplant should follow the principles of biliary reconstruction in cases with biliary injuries, extending the hilar opening into the left duct. Conclusion This case highlights the successful utilisation of a post bile duct injury repair liver, employing an experienced procurement team and careful bench assessment and reconstruction. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
41. Sidestream dark field videomicroscopy for evaluating liver microcirculation in vivo.
- Author
-
Wigmore, Stephen J. and Oniscu, Gabriel C.
- Published
- 2017
- Full Text
- View/download PDF
42. Faster may be better for anastomosis time, but does it really affect survival?
- Author
-
O'Neill, Stephen, Oniscu, Gabriel C., and Harrison, Ewen M.
- Subjects
- *
SURGICAL anastomosis , *KIDNEY transplantation , *TRANSPLANTATION of organs, tissues, etc. - Abstract
A letter to the editor is presented in response to a retrospective study which examined the influence of anastomosis time (AT) on outcomes after deceased donor kidney transplant.
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.